まとめ
合成ポリペプチド抗原は,ウサギの免疫反応を誘発した. この免疫耐性は特異的であり,動物は卵白素のような無関係な抗原に反応し続けていた.
科学分野:
- 免疫学 免疫学とは
- 実験医学は,実験医学である.
背景:
- 免疫学的な耐性は,自己免疫疾患の予防に不可欠です.
- 耐性誘発のメカニズムを理解することは,新しい免疫療法を開発する上で鍵となるものです.
研究 の 目的:
- 合成ポリペプチド抗原を用いて免疫的耐性の誘導を調査する.
- 誘発された免疫不反応の特異性を決定する.
主な方法:
- 成人ウサギは6-メルカプトプーリンを投与し,合成ポリペプチド抗原を注射した.
- 新生児のウサギに,同じ合成ポリペプチド抗原を注射した.
- 免疫反応を評価するために,その後の予防接種を行いました.
- 関連のない抗原 (オバルブミン) に対する反応性は,耐性のある動物で試験された.
主要な成果:
- 6マーカプトプリンを投与されたウサギや新生ウサギは,合成ポリペプチド抗原に対する免疫反応を欠いた.
- 誘発された耐性は特異的であり,動物はオバルブミンに対する無反応を示さなかった.
結論:
- 合成ポリペプチド抗原は,ウサギの特定の免疫的耐性を誘発することができます.
- このモデルは,免疫耐性誘導のメカニズムとその潜在的な応用に関する洞察を提供します.
関連する概念動画
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Cross-reactivity
Overview
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...


